Tobacco alternative gums are products such as nicotine gums, which are used by smokers to quit smoking. Nicotine gum is a smoking cessation product, which helps smokers to gradually get off nicotine. Nicotine released from chewing nicotine gum is absorbed into the bloodstream through the lining of the mouth. Nicotine gums help the human body battle the strong urges for nicotine after cutting down on cigarettes. They are available in various dosages and can be consumed according to the level of addiction.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Global smoking cessation market

Global tobacco alternative gums market

Five forces analysis

PART 06: Market segmentation by nicotine content

Global 2-mg nicotine gum market

Global 4-mg nicotine gum market

PART 07: Market segmentation by distribution channel

PART 08: Geographical segmentation

Tobacco alternative gums market in Americas

Tobacco alternative gums market in Europe

Tobacco alternative gums market in APAC

Tobacco alternative gums market in MEA

PART 09: Key leading countries

US

Germany

France

China

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

Competitive scenario

GlaxoSmithKline

Johnson & Johnson

Novartis

Reynolds American Incorporated

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: Explore Technavio